Anderegg M, Schietzel S, Bargagli M, Bally L, Faller N, Moor M
Nat Med. 2025; 31(1):286-293.
PMID: 39747681
PMC: 11750721.
DOI: 10.1038/s41591-024-03330-x.
Siener R, Ernsten C, Welchowski T, Hesse A
Nutrients. 2024; 16(16).
PMID: 39203825
PMC: 11357492.
DOI: 10.3390/nu16162688.
Zhou L, Ali A, Jayachandran M, Haskic Z, Harris P, Rule A
J Am Soc Nephrol. 2024; 35(12):1746-1757.
PMID: 39102294
PMC: 11617471.
DOI: 10.1681/ASN.0000000000000453.
Zaidan N, Wang C, Chen Z, Lieske J, Milliner D, Seide B
Kidney Int Rep. 2024; 9(6):1836-1848.
PMID: 38899198
PMC: 11184406.
DOI: 10.1016/j.ekir.2024.03.004.
Yau A
Kidney Int Rep. 2024; 9(3):721-724.
PMID: 38481489
PMC: 10927472.
DOI: 10.1016/j.ekir.2023.12.020.
Magnesium Decreases Urine Supersaturation but Not Calcium Oxalate Stone Formation in Genetic Hypercalciuric Stone-Forming Rats.
Li Q, Krieger N, Yang L, Asplin J, Bushinsky D
Nephron. 2024; 148(7):480-486.
PMID: 38262368
PMC: 11219255.
DOI: 10.1159/000534495.
Intestinal Oxalate Absorption, Enteric Hyperoxaluria, and Risk of Urinary Stone Formation in Patients with Crohn's Disease.
Siener R, Ernsten C, Speller J, Scheurlen C, Sauerbruch T, Hesse A
Nutrients. 2024; 16(2).
PMID: 38257157
PMC: 10821467.
DOI: 10.3390/nu16020264.
Drivers of calcium oxalate stone formation in the octogenarian population.
Khargi R, Blake R, Yaghoubian A, Canning C, Fang A, Connors C
World J Urol. 2023; 41(12):3713-3721.
PMID: 37847263
DOI: 10.1007/s00345-023-04619-1.
Contribution of thick ascending limb and distal convoluted tubule to glucose-induced hypercalciuria in healthy controls.
Prochaska M, Menezes C, Ko B, Coe F, Worcester E
Am J Physiol Renal Physiol. 2023; 325(6):F811-F816.
PMID: 37823200
PMC: 10874680.
DOI: 10.1152/ajprenal.00130.2023.
Risk Profile of Patients with Brushite Stone Disease and the Impact of Diet.
Siener R, Pitzer M, Speller J, Hesse A
Nutrients. 2023; 15(18).
PMID: 37764875
PMC: 10534559.
DOI: 10.3390/nu15184092.
Relative supersaturation values distinguish between feline urinary and non-urinary foods and align with expected urine analytes contributions to uroliths.
Morris E, McGrath A, Brejda J, Jewell D
Front Vet Sci. 2023; 10:1167840.
PMID: 37601750
PMC: 10436620.
DOI: 10.3389/fvets.2023.1167840.
Comparison of two software programs used to determine the relative supersaturation of urine ions.
Anthony R, Davidson S, MacLeay J, Brejda J, Werness P, Jewell D
Front Vet Sci. 2023; 10:1146945.
PMID: 37332737
PMC: 10274322.
DOI: 10.3389/fvets.2023.1146945.
Characterization of Stone Events in Patients With Type 3 Primary Hyperoxaluria.
Arnous M, Vaughan L, Mehta R, Schulte P, Lieske J, Milliner D
J Urol. 2023; 209(6):1141-1150.
PMID: 36888927
PMC: 11034812.
DOI: 10.1097/JU.0000000000003400.
Urinary Risk Profile, Impact of Diet, and Risk of Calcium Oxalate Urolithiasis in Idiopathic Uric Acid Stone Disease.
Siener R, Lohr P, Hesse A
Nutrients. 2023; 15(3).
PMID: 36771279
PMC: 9919786.
DOI: 10.3390/nu15030572.
The role of urinary supersaturations for lithogenic salts in the progression of autosomal dominant polycystic kidney disease.
Ferraro P, Bargagli M, Faller N, Anderegg M, Huynh-Do U, Vogt B
J Nephrol. 2022; 36(4):1011-1018.
PMID: 36528688
DOI: 10.1007/s40620-022-01540-5.
Effect of Two Different Dietary Weight Loss Strategies on Risk Factors for Urinary Stone Formation and Cardiometabolic Risk Profile in Overweight Women.
Siener R, Ernsten C, Bitterlich N, Alteheld B, Metzner C
Nutrients. 2022; 14(23).
PMID: 36501084
PMC: 9736858.
DOI: 10.3390/nu14235054.
Clinical Effectiveness of Calcium Oxalate Stone Treatments.
Gutbrod J, Keys McKay C, Coe L, Bergsland K, Coe F, Worcester E
Am J Nephrol. 2022; 53(10):761-766.
PMID: 36412567
PMC: 9877156.
DOI: 10.1159/000527940.
Differences of Uric Acid Transporters Carrying Extracellular Vesicles in the Urine from Uric Acid and Calcium Stone Formers and Non-Stone Formers.
Lin Z, Jayachandran M, Haskic Z, Kumar S, Lieske J
Int J Mol Sci. 2022; 23(17).
PMID: 36077407
PMC: 9456222.
DOI: 10.3390/ijms231710010.
What treatments reduce kidney stone risk in patients with bowel disease?.
Bianco J, Chu F, Bergsland K, Coe F, Worcester E, Prochaska M
Urolithiasis. 2022; 50(5):557-565.
PMID: 35976425
PMC: 9972896.
DOI: 10.1007/s00240-022-01352-z.
Cats with Genetic Variants of AGXT2 Respond Differently to a Dietary Intervention Known to Reduce the Risk of Calcium Oxalate Stone Formation.
Hall J, Panickar K, Brockman J, Jewell D
Genes (Basel). 2022; 13(5).
PMID: 35627178
PMC: 9141165.
DOI: 10.3390/genes13050791.
